Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

4,169 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Endoscopic evaluation of gastro-esophageal reflux disease.
Armstrong D. Armstrong D. Yale J Biol Med. 1999 Mar-Jun;72(2-3):93-100. Yale J Biol Med. 1999. PMID: 10780570 Free PMC article. Review.
(Los Angeles) classification describes four grades of esophagitis severity (A to D), based on the extent of esophageal lesions known as "mucosal breaks," but it does not record the presence or severity of other GERD lesions. ...
(Los Angeles) classification describes four grades of esophagitis severity (A to D), based on the extent of esophageal lesions known …
An evidence-based, Latin-American consensus on gastro-oesophageal reflux disease.
Cohen H, Moraes-Filho JP, Cafferata ML, Tomasso G, Salis G, González O, Valenzuela J, Sharma P, Malfertheiner P, Armstrong D, Lundell L, Corti R, Sakai P, Ceconello I; Latin-American GORD Consensus Group. Cohen H, et al. Eur J Gastroenterol Hepatol. 2006 Apr;18(4):349-68. doi: 10.1097/00042737-200604000-00008. Eur J Gastroenterol Hepatol. 2006. PMID: 16538106
The gain in quality-adjusted life months by switching to esomeprazole in those with continued reflux symptoms in primary care: EncomPASS--a cluster-randomized trial.
Moayyedi P, Armstrong D, Hunt RH, Lei Y, Bukoski M, White RJ. Moayyedi P, et al. Am J Gastroenterol. 2010 Nov;105(11):2341-6. doi: 10.1038/ajg.2010.368. Epub 2010 Sep 14. Am J Gastroenterol. 2010. PMID: 20842110 Clinical Trial.
New pharmacologic approaches in gastroesophageal reflux disease.
Armstrong D, Sifrim D. Armstrong D, et al. Thorac Surg Clin. 2011 Nov;21(4):557-74. doi: 10.1016/j.thorsurg.2011.09.005. Thorac Surg Clin. 2011. PMID: 22040637 Review.
The impact of illness in patients with moderate to severe gastro-esophageal reflux disease.
El-Dika S, Guyatt GH, Armstrong D, Degl'innocenti A, Wiklund I, Fallone CA, Tanser L, Veldhuyzen van Zanten S, Heels-Ansdell D, Wahlqvist P, Chiba N, Barkun AN, Austin P, Schünemann HJ. El-Dika S, et al. BMC Gastroenterol. 2005 Jul 10;5:23. doi: 10.1186/1471-230X-5-23. BMC Gastroenterol. 2005. PMID: 16004616 Free PMC article.
Esomeprazole 40 mg and 20 mg is efficacious in the long-term management of patients with endoscopy-negative gastro-oesophageal reflux disease: a placebo-controlled trial of on-demand therapy for 6 months.
Talley NJ, Venables TL, Green JR, Armstrong D, O'Kane KP, Giaffer M, Bardhan KD, Carlsson RG, Chen S, Hasselgren GS. Talley NJ, et al. Eur J Gastroenterol Hepatol. 2002 Aug;14(8):857-63. doi: 10.1097/00042737-200208000-00008. Eur J Gastroenterol Hepatol. 2002. PMID: 12172406 Clinical Trial.
Validation of the GSFQ, a self-administered symptom frequency questionnaire for patients with gastroesophageal reflux disease.
Paré P, Meyer F, Armstrong D, Pyzyk M, Pericak D, Goeree R. Paré P, et al. Can J Gastroenterol. 2003 May;17(5):307-12. doi: 10.1155/2003/530984. Can J Gastroenterol. 2003. PMID: 12772004 Clinical Trial.
The construction of a new evaluative GERD questionnaire--methods and state of the art.
Armstrong D, Mönnikes H, Bardhan KD, Stanghellini V. Armstrong D, et al. Digestion. 2007;75 Suppl 1:17-24. doi: 10.1159/000101078. Epub 2007 May 4. Digestion. 2007. PMID: 17489028 Review.
4,169 results
Jump to page
Feedback